First Blog Post In Series Examines History Of Artemisinin Development

Council on Foreign Relations’ “Asia Unbound”: Artemisinin’s Rocky Road to Globalization: Part I
Yanzhong Huang, CFR senior fellow for global health, examines the history of artemisinin drug development in China during the Cold War era. “…It would take another two decades before [artemisinin-combination therapies (ACTs)] were officially adopted by the World Health Organization (WHO) as frontline drugs in the global fight against malaria. Paradoxically, even today artemisinin-based drugs made in China only accounts for one percent of the international market share. Why? This will be the subject of my next blog post” (2/27).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.